1. Home
  2. NTWK vs KZR Comparison

NTWK vs KZR Comparison

Compare NTWK & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

HOLD

Current Price

$4.52

Market Cap

53.7M

Sector

Technology

ML Signal

HOLD

Logo Kezar Life Sciences Inc.

KZR

Kezar Life Sciences Inc.

HOLD

Current Price

$7.29

Market Cap

54.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
KZR
Founded
1997
2015
Country
United States
United States
Employees
1460
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
54.2M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
NTWK
KZR
Price
$4.52
$7.29
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$6.00
AVG Volume (30 Days)
33.5K
226.1K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
316.67
33.33
EPS
N/A
N/A
Revenue
$73,088,687.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.40
N/A
52 Week Low
$2.73
$3.53
52 Week High
$5.75
$7.55

Technical Indicators

Market Signals
Indicator
NTWK
KZR
Relative Strength Index (RSI) 62.54 54.64
Support Level $4.55 $7.25
Resistance Level $4.86 $7.47
Average True Range (ATR) 0.26 0.11
MACD -0.03 -0.02
Stochastic Oscillator 67.72 37.50

Price Performance

Historical Comparison
NTWK
KZR

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: